Get Your Personalized Supplement StackSupplement Stack Quiz

Hemidesmus Indicus

Also known as: Indian Sarsaparilla, Anantamool, *Hemidesmus indicus*

Overview

*Hemidesmus indicus* is a plant native to India, traditionally utilized in Ayurvedic medicine for its various health benefits. Its main applications include anti-inflammatory, antioxidant, and antiviral actions. The plant is rich in bioactive compounds such as saponins, tannins, phenols, terpenoids, flavonoids, and coumarins that contribute to its therapeutic potential. Despite its long-standing use in traditional practices, research on *Hemidesmus indicus* is still developing, focusing primarily on in vitro and in vivo effects rather than robust clinical studies in humans. Thus, while the extract is recognized for its bioactivity, the quality of evidence remains limited due to a lack of rigorous human trials.

Benefits

*Hemidesmus indicus* has demonstrated notable antiviral activity against herpes simplex viruses HSV-1 and HSV-2 with effective concentrations (EC50) of 91.3 μg/mL and 86.1 μg/mL, respectively. Additionally, its antioxidant and anti-inflammatory properties suggest potential benefits for conditions like ulcerative colitis, where it may alleviate inflammation and oxidative stress. Observations indicate its protective potential against genotoxicity induced by cisplatin in animal models, though human applicability remains untested. The evidence primarily derives from in vitro studies and animal trials, underscoring the need for human-centric research to establish clinical significance.

How it works

*Hemidesmus indicus* is thought to exert its benefits through multiple mechanisms. It may inhibit the attachment and entry of viruses into cells, facilitating a reduction in viral replication. Additionally, the plant's antioxidant properties help combat oxidative stress, while its anti-inflammatory effects modulate immune response pathways. Key biological targets include α-glucosidases, which play a role in its antiviral action. However, further studies are required to clarify the specific mechanisms at play and the bioavailability of its active compounds in humans.

Side effects

The safety profile of *Hemidesmus indicus* is not well established, primarily due to a lack of extensive human studies. Some existing research indicates potential cytotoxicity at high doses, although specific side effects remain poorly documented. Due to the limited data, potential interactions with other drugs are unknown, and no contraindications have been formally reported. Moreover, pregnant or breastfeeding individuals are advised to use caution given the insufficient safety data. Comprehensive safety assessments are essential before broader recommendations can be made.

Dosage

Currently, there are no established recommended dosages for humans. Animal studies have explored dosage ranges from 10 to 400 mg/kg body weight. While extracts are commonly utilized in aqueous or hydroalcoholic forms, factors impacting absorption and specific timing for effectiveness have not been well-documented. Moreover, maximum safe doses have not been identified for human consumption, necessitating careful consideration in its application until more robust data are available.

FAQs

What is the recommended dosage for *Hemidesmus indicus*?

There are no established dosages for humans; recommendations are primarily based on animal studies, which range from 10 to 400 mg/kg.

Are there any known side effects?

Side effects are not well documented; however, some research suggests potential cytotoxicity at high doses.

Is it safe to use during pregnancy?

Safety during pregnancy is not established, thus caution is advised for pregnant or breastfeeding women.

What are the main benefits of this supplement?

Benefits include antiviral effects against HSV and potential antioxidant and anti-inflammatory actions.

Why is there limited research on humans?

Most studies focus on in vitro or animal models, lacking robust clinical trials that provide direct evidence in humans.

Research Sources

https://www.newmicrobiologica.org/PUB/allegati_pdf/2018/3/187.pdf – An in vitro study demonstrating the antiviral effects of *Hemidesmus indicus* against HSV-1 and HSV-2, with notable EC50 values, though limited by a lack of human clinical trials.
https://www.scielo.br/j/gmb/a/NmZknrGMRXMBLVTwMRqgyjz/?lang=en – This in vivo study highlighted the antigenotoxic effects of *Hemidesmus indicus* in mice against cisplatin-induced genotoxicity, recommending further investigation in human subjects.
https://www.ijper.org/sites/default/files/IndJPhaEdRes-56-3s-s487.pdf – An animal study exploring the effects of *Hemidesmus indicus* var. pubescens in ulcerative colitis, suggesting beneficial anti-inflammatory and antioxidant properties but underlining the lack of clinical human studies.
https://japsonline.com/abstract.php?article_id=4115&sts=2 – Examines the variability of bioactive compounds in *Hemidesmus indicus* extracts and their implications on therapeutic efficacy, advocating for more rigorous human trials.
https://pubmed.ncbi.nlm.nih.gov/32007632/ – Provides insights into the pharmacological activities of *Hemidesmus indicus*, including its potential antiviral properties, and discusses the need for further clinical research.